MENU
REGN
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Regeneron Pharmaceuticals (REGN) Ownership - Who owns Regeneron Pharmaceuticals?
Industry: @Biotechnology
Profile
Industry
Biotechnology
Address
777 Old Saw Mill River Road
Phone
+1 914 847-7000
Employees
13450
Web
https://www.regeneron.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
114.94B
P/E Ratio
27.61
Total Cash
N/A
Projected Growth
1.42
Total Debt
N/A
Revenue
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash/Share
N/A
Total Debt/Equity
24.02
Revenue/Share
117.91 USD as % of share price
Fundamentals
REGN
Capitalization
115B
P/E Ratio
27.61
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash
N/A
Total Cash/Share
N/A
Total Debt
N/A
Total Debt/Equity
24.02
Projected Growth (PEG Ratio)
1.42
Revenue/Share (as % of the share price)
117.91%
Revenue
N/A
ROE
N/A
Book Value
N/A
P/B Ratio
4.07
Cash Flow
N/A
Earnings
N/A
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
N/A
Current Ratio
N/A
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
N/A
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
N/A
Shares Held By Institutions
N/A
Shares Outstanding - Current
110M
Total Liabilities
N/A
Total Volume MTD
N/A
Value
-1
Gain YTD
33.078
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a developer of medicines for the treatment of serious medical conditions
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Biotechnology
Address
777 Old Saw Mill River Road
Phone
+1 914 847-7000
Employees
13450
Web
https://www.regeneron.com